Fred A Middleton - Net Worth and Insider Trading
Fred A Middleton Net Worth
The estimated net worth of Fred A Middleton is at least $97 Million dollars as of 2023-09-26. Fred A Middleton is the Director of Endocyte Inc and owns about 3,746,616 shares of Endocyte Inc (ECYT) stock worth over $90 Million. Fred A Middleton is the Director, 10% Owner of CalciMedica Inc and owns about 1,659,934 shares of CalciMedica Inc (CALC) stock worth over $4 Million. Fred A Middleton is also the Director of Pacira BioSciences Inc and owns about 70,399 shares of Pacira BioSciences Inc (PCRX) stock worth over $2 Million. Besides these, Fred A Middleton also holds Chimerix Inc (CMRX) . Details can be seen in Fred A Middleton's Latest Holdings Summary section.
Transaction Summary of Fred A Middleton
Fred A Middleton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fred A Middleton owns 5 companies in total, including Chimerix Inc (CMRX) , Endocyte Inc (ECYT) , and Stereotaxis Inc (STXS) among others .
Click here to see the complete history of Fred A Middleton’s form 4 insider trades.
Insider Ownership Summary of Fred A Middleton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CMRX | Chimerix Inc | 2018-03-28 | director |
| ECYT | Endocyte Inc | 2018-12-21 | director |
| STXS | Stereotaxis Inc | 2004-08-11 | director |
| PCRX | Pacira BioSciences Inc | 2011-11-21 | director & 10 percent owner |
| CALC | CalciMedica Inc | 2023-03-20 | director & 10 percent owner |
Fred A Middleton Latest Holdings Summary
Fred A Middleton currently owns a total of 4 stocks. Among these stocks, Fred A Middleton owns 3,746,616 shares of Endocyte Inc (ECYT) as of January 19, 2016, with a value of $90 Million and a weighting of 92.20999999999999%. Fred A Middleton owns 1,659,934 shares of CalciMedica Inc (CALC) as of June 9, 2023, with a value of $4 Million and a weighting of 4.58%. Fred A Middleton also owns 70,399 shares of Pacira BioSciences Inc (PCRX) as of June 24, 2013, with a value of $2 Million and a weighting of 2.4%. The other 1 stocks Chimerix Inc (CMRX) have a combined weighting of 0.8100000000000001% among all his current holdings.
Latest Holdings of Fred A Middleton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ECYT | Endocyte Inc | 2016-01-19 | 3,746,616 | 23.99 | 89,881,318 |
| CALC | CalciMedica Inc | 2023-06-09 | 1,659,934 | 2.69 | 4,465,388 |
| PCRX | Pacira BioSciences Inc | 2013-06-24 | 70,399 | 33.20 | 2,337,247 |
| CMRX | Chimerix Inc | 2023-03-28 | 802,830 | 0.98 | 789,583 |
Holding Weightings of Fred A Middleton
Fred A Middleton Form 4 Trading Tracker
According to the SEC Form 4 filings, Fred A Middleton has made a total of 0 transactions in Endocyte Inc (ECYT) over the past 5 years. The most-recent trade in Endocyte Inc is the acquisition of 30,000 shares on January 19, 2016, which cost Fred A Middleton around $84,000.
According to the SEC Form 4 filings, Fred A Middleton has made a total of 3 transactions in CalciMedica Inc (CALC) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in CalciMedica Inc is the acquisition of 714 shares on June 9, 2023, which cost Fred A Middleton around $3,713.
According to the SEC Form 4 filings, Fred A Middleton has made a total of 0 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years. The most-recent trade in Pacira BioSciences Inc is the sale of 75,900 shares on June 24, 2013, which brought Fred A Middleton around $2 Million.
More details on Fred A Middleton's insider transactions can be found in the Insider Trading History of Fred A Middleton table.Insider Trading History of Fred A Middleton
- 1
Fred A Middleton Trading Performance
GuruFocus tracks the stock performance after each of Fred A Middleton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fred A Middleton is 22.07%. GuruFocus also compares Fred A Middleton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Fred A Middleton within 3 months outperforms 9 times out of 16 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Fred A Middleton's insider trading performs compared to the benchmark.
Performance of Fred A Middleton
Average Relative Return
108.81%
Outperforming Transactions
58%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 3.67 | 22.07 | 41.87 | 108.81 | 68.12 | 41.7 |
| Relative Return to S&P 500(%) | -0.16 | 13.11 | 33.55 | 93.65 | 49 | 26.35 |
Fred A Middleton Ownership Network
Ownership Network List of Fred A Middleton
Ownership Network Relation of Fred A Middleton
Fred A Middleton Owned Company Details
What does Chimerix Inc do?
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals.
Who are the key executives at Chimerix Inc?
Fred A Middleton is the director of Chimerix Inc. Other key executives at Chimerix Inc include Chief Medical Officer Allen S. Melemed , 10 percent owner Cantex Pharmaceuticals, Inc. , and Principal Accounting Officer David Jakeman .
Chimerix Inc (CMRX) Insider Trades Summary
Over the past 18 months, Fred A Middleton made 3 insider transaction in Chimerix Inc (CMRX) with a net purchase of 60,000. Other recent insider transactions involving Chimerix Inc (CMRX) include a net purchase of 28,000 shares made by Martha J Demski , a net sale of 7,630 shares made by David Jakeman , and a net purchase of 87,000 shares made by Michael A. Sherman .
In summary, during the past 3 months, insiders sold 0 shares of Chimerix Inc (CMRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,630 shares of Chimerix Inc (CMRX) were sold and 198,750 shares were bought by its insiders, resulting in a net purchase of 191,120 shares.
Chimerix Inc (CMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Chimerix Inc Insider Transactions
Fred A Middleton Mailing Address
Above is the net worth, insider trading, and ownership report for Fred A Middleton. You might contact Fred A Middleton via mailing address: 400 South El Camino Real Ste 1200, San Mateo Ca 94402-1708.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
